DNA Sequencing Market Size is Projected to reach USD 40.64 Billion by 2030

Spread the love

The global DNA sequencing market size was valued at US$ 8.41 Billion in 2020 and is projected to reach US$ 40.64 Billion by 2030, rising at a market growth (CAGR) of 17.5% during the forecast period. Precedence Research’s latest report on the global DNA sequencing market provides an analysis for the period of 2017 to 2030, wherein, 2020 is the base year, 2017 and before is historical data, and 2021 to 2030 is the forecast period.

Precedence Research provides an in-depth analysis of market size, share analysis, Industry growth, market valuation, market dynamics which includes drivers, restraints, opportunities, trends, challenges, market segmentation, competitive landscape, regional and country breakdowns, and strategies for DNA sequencing market. The study reviews the global industry by-products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context, and more.

The report comprises a detailed value chain analysis, which provides a comprehensive view of this market. The Porter’s Five Forces model for the global market has also been included to help understand the competitive landscape. The study covers market attractiveness analysis, wherein resin types are benchmarked based on their market value, growth rate, and general attractiveness.

Download FREE SAMPLE PAGES before Purchase https://www.precedenceresearch.com/sample/1189

DNA sequencing is a procedure used to ascertain the nucleotide sequence of DNA (deoxyribonucleic acid). The nucleotide sequence is a blueprint that encompasses the directives for building an organism, and no perception of the genetic function or progression can be complete without gaining this data. The nucleotide sequence is thus an essential level of information of a genome or gene. Sequencing a complete genome is a complex task that requires separating the DNA of the genome into numerous smaller fragments, sequencing the fragments, and gathering the sequences into a sole long consensus.

The early methods of sequencing (also known as first-generation sequencing technologies) were developed in the 1970s which included Maxam-Gilbert and Sanger method. However, next-generation sequencing methods have mostly supplanted the first-generation methods. These newer methods enable numerous DNA fragments (occasionally on the order of millions of strands) to be sequenced at one time and are more cost-effective and much quicker than first-generation methods. The efficacy of next-generation methods was enhanced significantly by advances in the field of bioinformatics that allowed for augmented data storage and helped the analysis and handling of very big data sets.

Growth Factors

Factors such as constant technological advancements in the sequencing methods, developments in the field of bioinformatics, increasing applications of NGS (Next-generation Sequencing) and WGS (Whole-genome Sequencing), growing prevalence of viral diseases such as SARS and COVID-19, increasing cases of cancer globally, and growing research and development expenditure are propelling the DNA sequencing market expansion across the globe. Additional aspects that are anticipated to fuel this industry are applications in cancer research, biomarker discovery, personalized medicine, genomic analysis, and forensics. Constant collaborations and partnerships between major market players in order to launch new and innovative technologies have enhanced the demand for overall market for the DNA sequencing market.

DNA sequencing also has applications in the field of animal and plant breeding. Selecting the finest animals for next generation breeding is needs an in-depth understanding of the livestock genetics. Genomics technologies are entirely established in breeding and are becoming further competent due to technology innovations and progresses. The area of modern farming has instituted techniques such as genome sequencing, genome wide association, genotyping, and genetic markers. Moreover, genome sequencing has reached satisfactory success in beef cattle and milk cow breeding with enhanced properties in characters such as milk yield, beef quality, feed efficiency, and health.

Report Highlights

  • Among the product segment, consumables are expected to dominate the overall market. High requirement for consumables such as reagents and kits for DNA fragmentation and amplification is the major reason for high market share of consumables.
  • The next-generation sequencing accounted for the largest revenue in the technology segment with more than 52% share in 2020. Factors such as tremendous advances in NGS technologies along with reduction in cost drive the growth if next-generation sequencing technologies.
  • Oncology accounted for the largest revenue in the application segment. High prevalence of cancer in developing regions is the key reason for high market share of oncology.
  • Academic research centers accounted for the largest revenue in the end-use segment. High investment in research and development is the key reason for high market share of academic research centers.
  • Illumina, Inc. accounted for a significant share of the global DNA sequencing market.

Key Players of the global DNA sequencing market are:

  • Agilent Technologies
  • Illumina, Inc.
  • QIAGEN
  • Perkin Elmer
  • Thermo Fisher Scientific
  • Hoffmann-La Roche Ltd.
  • Macrogen, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Myriad Genetics

Segments Covered in the Report:

Market Segment

By Product

  • Instruments
  • Consumables
  • Services

By Technology

  • Third Generation DNA Sequencing
  • Next-Generation Sequencing
  • Sanger Sequencing

By Application

  • Clinical Investigation
  • Oncology
  • Forensics & Agrigenomics
  • Reproductive Health
  • HLA Typing
  • Others

By End-Use

  • Clinical Research
  • Academic Research
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics
  • Others

Regional Segment

  • North America (United States, Canada)
  • Europe (Germany, France, UK,  Italy, Russia, and Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia, Korea, and Rest of Asia Pacific)
  • Latin America (Brazil and the Rest of Latin America)
  • The Middle East and Africa (GCC, North Africa, South Africa, and Rest of the Middle East & Africa)

Regional Analysis:

The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2020, North America dominated the global market with a market share of more than 42%. U.S. represented the highest share in the North American region primarily due to presence of leading market players and high awareness regarding next-generation sequencing technologies. Furthermore, early adoption of latest sequencing technologies also contributed to the high market share of the United States.

Europe was the second important market chiefly due to high investment in research and development and presence of skilled researchers. High incidence of cancer in the European region is also expected to boost the demand for DNA Sequencing market in the near future. Asia Pacific is anticipated to grow at the maximum CAGR of around14% in the forecast period due to high incidence of viral disorders. Latin America and the African and Middle Eastern region will display noticeable growth.

Purchase this Market Research Report @ https://www.precedenceresearch.com/checkout/1189

About Us:

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Admin

Carolina is an author who specializes in covering healthcare, chemical, and the automotive industry. Before joining Market Stats News, Carolina covered some of the biggest companies in Silicon Valley for the San Jose Mercury News. She loves all things French and the written word. Articles by Carolina

Mail: carolina@marketstatsnews.com

View all posts by Admin →

Leave a Reply

Your email address will not be published. Required fields are marked *